Kingworld Medicines Group Limited (HKG:1110)
Hong Kong
· Delayed Price · Currency is HKD 0.465
0.00 (0.00%)
Apr 29, 2026, 3:58 PM HKT
Kingworld Medicines Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 11.28 | 41.56 | 38.1 | 22.74 | 30.32 | Upgrade
|
| Depreciation & Amortization | 26 | 20.15 | 20.08 | 38.19 | 34.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.74 | 0.34 | 0.21 | 0.05 | 1.3 | Upgrade
|
| Asset Writedown & Restructuring Costs | -6.84 | -3.93 | 1.36 | 7.3 | -0.8 | Upgrade
|
| Loss (Gain) From Sale of Investments | 8.32 | 4.25 | -12.94 | -2.89 | -0.47 | Upgrade
|
| Loss (Gain) on Equity Investments | -8.32 | -19.1 | -8.6 | -7.64 | -8.99 | Upgrade
|
| Stock-Based Compensation | 1.63 | 3.61 | 1.96 | 0.73 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.1 | 0.2 | 0.44 | 1.04 | 0.05 | Upgrade
|
| Other Operating Activities | 28.33 | 37.94 | 33 | 33.77 | 40.26 | Upgrade
|
| Change in Accounts Receivable | 0.12 | -5.22 | 30.2 | 50.07 | -11.5 | Upgrade
|
| Change in Inventory | -9.45 | -0.3 | -41.15 | 21.47 | 16.51 | Upgrade
|
| Change in Accounts Payable | 2.86 | 10.31 | 49.55 | 35.92 | -35.5 | Upgrade
|
| Change in Unearned Revenue | 6.5 | 2.72 | -0.37 | -14.19 | 15.23 | Upgrade
|
| Change in Other Net Operating Assets | 22.29 | 43.29 | -69.55 | - | - | Upgrade
|
| Operating Cash Flow | 84.56 | 135.82 | 42.28 | 186.55 | 81.2 | Upgrade
|
| Operating Cash Flow Growth | -37.74% | 221.21% | -77.33% | 129.74% | -34.30% | Upgrade
|
| Capital Expenditures | -29.64 | -41.09 | -105.54 | -93.51 | -58.32 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.43 | - | 0.02 | 0.11 | 1.57 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | -7.48 | - | - | Upgrade
|
| Investment in Securities | 0.21 | 5.09 | -44.16 | -3 | -4.88 | Upgrade
|
| Other Investing Activities | 8.9 | 8.36 | 36.52 | 12.35 | 10.8 | Upgrade
|
| Investing Cash Flow | -20.11 | -27.64 | -120.63 | -84.05 | -50.84 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 124.68 | Upgrade
|
| Long-Term Debt Issued | 430.22 | 436.15 | 327.51 | 373.37 | - | Upgrade
|
| Total Debt Issued | 430.22 | 436.15 | 327.51 | 373.37 | 124.68 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -187.18 | Upgrade
|
| Long-Term Debt Repaid | -406.35 | -398.41 | -267.16 | -348.16 | -8.15 | Upgrade
|
| Total Debt Repaid | -406.35 | -398.41 | -267.16 | -348.16 | -195.33 | Upgrade
|
| Net Debt Issued (Repaid) | 23.87 | 37.74 | 60.34 | 25.21 | -70.65 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 2.46 | Upgrade
|
| Repurchase of Common Stock | -0.3 | -4.81 | -8.71 | -5.04 | - | Upgrade
|
| Common Dividends Paid | -18.15 | -19.78 | -13.92 | -13.29 | -3.3 | Upgrade
|
| Other Financing Activities | -36.25 | -60.77 | -33.34 | -58.19 | -15.7 | Upgrade
|
| Financing Cash Flow | -30.82 | -47.61 | 4.37 | -51.31 | -87.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | -4.53 | 1.05 | 5.5 | 3.04 | -6.06 | Upgrade
|
| Net Cash Flow | 29.11 | 61.62 | -68.48 | 54.23 | -62.89 | Upgrade
|
| Free Cash Flow | 54.92 | 94.73 | -63.25 | 93.04 | 22.88 | Upgrade
|
| Free Cash Flow Growth | -42.03% | - | - | 306.62% | -79.87% | Upgrade
|
| Free Cash Flow Margin | 5.99% | 8.93% | -5.86% | 9.71% | 2.70% | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.16 | -0.11 | 0.15 | 0.04 | Upgrade
|
| Cash Interest Paid | 14.05 | 13.28 | 11.52 | 12.29 | 11.78 | Upgrade
|
| Cash Income Tax Paid | 18.61 | 21.19 | 30.48 | 22.13 | 14.8 | Upgrade
|
| Levered Free Cash Flow | 52.3 | 88.36 | -64.91 | 87.37 | 10.66 | Upgrade
|
| Unlevered Free Cash Flow | 61.08 | 96.66 | -57.71 | 95.05 | 18.03 | Upgrade
|
| Change in Working Capital | 22.32 | 50.8 | -31.31 | 93.26 | -15.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.